FTRE Fortrea Holdings Inc.

FTRE Fortrea Holdings Inc.

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-08-17 1 bull converging

POC $10.21 · VWAP $13.07 · +38.5% vs 12m avg buyer

pullback vol: normalgaps: stablechurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

1 watchlist

FTRE Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist FTRE belongs to, members best 30-day change first — FTRE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

Jul 2 enter high Margin turn +7.9% complete

Next earnings FTRE reports in 79 days Nov 5

Against street estimates

How FTRE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 29 · projection Aug 17

Result
Jul 29 0.180.23+27.2%Beat
May 5 0.050.16 GAAP ≠ +211.9%Beat
Feb 26 0.160.09-43.8%Miss
Nov 5 '25 0.160.12 GAAP ≠ -25.7%Miss
Aug 6 '25 0.080.19 GAAP ≠ +152.5%Beat
May 12 '25 -0.070.02 GAAP ≠ +130.3%Beat
Mar 3 '25 0.370.18-50.7%Miss
Nov 8 '24 0.250.23 GAAP ≠ -8.3%Miss

News (last pull)

Headlines about FTRE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 58 days ago · Jun 21